TP53 and osteosarcoma: This model is potentiated by Rb1 loss (Tp53/Rb1 DKO; Osx-cre Tp53lox/loxRb1lox/lox), mimicking the poor clinical outcome of RB1 loss in human osteosarcoma [34, 35].